Cargando…
Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy
Objective: To examine relationships between cerebrospinal fluid (CSF) Alzheimer' disease (AD) biomarkers and hypocretin-1 levels in patients with cognitive abnormalities and hypocretin-deficient narcolepsy-cataplexy (NC), estimate diagnostic accuracy, and determine correlations with sleep distu...
Autores principales: | Dauvilliers, Yves A., Lehmann, Sylvain, Jaussent, Isabelle, Gabelle, Audrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052448/ https://www.ncbi.nlm.nih.gov/pubmed/24966833 http://dx.doi.org/10.3389/fnagi.2014.00119 |
Ejemplares similares
-
Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and
Histamine in Narcolepsy
por: Lopez, Régis, et al.
Publicado: (2017) -
Increased Immune Complexes of Hypocretin Autoantibodies in Narcolepsy
por: Deloumeau, Aude, et al.
Publicado: (2010) -
From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid
por: Hirtz, Christophe, et al.
Publicado: (2016) -
Low Vitamin D in Narcolepsy with Cataplexy
por: Carlander, Bertrand, et al.
Publicado: (2011) -
Non-Dipping Blood Pressure Profile in Narcolepsy with Cataplexy
por: Dauvilliers, Yves, et al.
Publicado: (2012)